Загрузка...
Metformin inhibits development of diabetic retinopathy through microRNA-497a-5p
Metformin is an AMP-activated protein kinase activator that is widely prescribed for treating type 2 diabetes. Recently, metformin was reported to slow down the development and alleviate the severity of diabetic retinopathy (DR). However, the underlying mechanisms remain unclear. Here, we used an al...
Сохранить в:
| Опубликовано в: : | Am J Transl Res |
|---|---|
| Главные авторы: | , , |
| Формат: | Artigo |
| Язык: | Inglês |
| Опубликовано: |
e-Century Publishing Corporation
2017
|
| Предметы: | |
| Online-ссылка: | https://ncbi.nlm.nih.gov/pmc/articles/PMC5752905/ https://ncbi.nlm.nih.gov/pubmed/29312507 |
| Метки: |
Добавить метку
Нет меток, Требуется 1-ая метка записи!
|